Hope-Focused Motivational Interviewing in Cancer Patients
Effects of Hope-Focused Motivational Interviewing on Hope, Self-Efficacy, and Self-Compassion in Cancer Patients Undergoing Radiotherapy: A Randomized Controlled Trial
1 other identifier
interventional
46
1 country
1
Brief Summary
This study aims to examine the effects of hope-focused motivational interviewing on levels of hope, self-efficacy, and self-compassion in patients with cancer receiving radiotherapy, using a randomized controlled design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2026
CompletedFirst Posted
Study publicly available on registry
May 14, 2026
CompletedStudy Start
First participant enrolled
June 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2026
Study Completion
Last participant's last visit for all outcomes
December 30, 2026
May 14, 2026
May 1, 2026
5 months
May 2, 2026
May 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Herth Hope Index
The scale consists of 12 items and three subscales: (1) temporality and future, (2) positive readiness and expectancy, and (3) interconnectedness with self and others. Items are rated on a 4-point Likert scale ranging from 0 (strongly disagree) to 3 (strongly agree). The "temporality and future" subscale (items 1, 2, 6, and 11) assesses the temporal dimension of hope; the "positive readiness and expectancy" subscale (items 4, 7, 10, and 12) reflects the emotional-behavioral aspects of hope; and the "interconnectedness" subscale (items 3, 5, 8, and 9) measures relational and contextual aspects of hope. Items 3 and 6 are negatively worded and are reverse scored. The total scale score is obtained by summing responses to all items, while subscale scores are calculated by summing the corresponding items. Total scores range from 12 to 48, with higher scores indicating greater levels of hope.
Baseline, immediately after the 2-week intervention, and 1 month post-intervention
Secondary Outcomes (2)
Brief Self-Compassion Scale
Baseline, immediately after the 2-week intervention, and 1 month post-intervention
General Self-Efficacy Scale
Baseline, immediately after the 2-week intervention, and 1 month post-intervention
Study Arms (2)
Experimental
EXPERIMENTALParticipants in the intervention group will receive an individual-based Hope-Focused Motivational Interviewing program consisting of four sessions delivered twice weekly.
Control
NO INTERVENTIONParticipants in the control group will receive routine care only and will not be exposed to any structured psychosocial intervention during the study period. Data will be collected at the same time points as the intervention group (baseline, post-test, and 1-month follow-up).
Interventions
Participants in the intervention group will receive an individual-based Hope-Focused Motivational Interviewing program consisting of four sessions delivered twice weekly. Each session will last approximately 30-40 minutes. The program includes the following components: (1) exploration of hope and goal setting, (2) enhancement of self-efficacy, (3) development of self-compassion, and (4) coping with barriers and creating a sustainable coping plan. Assessments will be conducted at baseline (pre-test), post-intervention, and at 1-month follow-up.
Eligibility Criteria
You may qualify if:
- Being 18 years of age or older
- Having a diagnosis of Stage I-III cancer according to the TNM staging system Receiving radiotherapy at the study center (including adjuvant, neoadjuvant, or definitive RT)
- Being in the first week of the radiotherapy process
- Being able to read and understand Turkish and communicate at a level sufficient to participate in interviews
- Agreeing to attend the intervention sessions at scheduled times and providing written informed consent
You may not qualify if:
- Presence of metastatic disease (Stage IV) or recurrent cancer
- Receiving concurrent chemotherapy during the radiotherapy process
- Presence of severe psychiatric conditions that may interfere with participation or the safe implementation of the intervention (e.g., psychotic disorders, bipolar disorder in the manic phase, or severe major depression)
- Presence of moderate to severe cognitive impairment/dementia, significant attention or concentration problems, or neurological conditions that may compromise the reliability of responses
- Severe hearing or speech impairments or communication difficulties that would prevent participation in interviews or completion of questionnaires (if appropriate support cannot be provided)
- Participation in another structured psychosocial intervention program (e.g., hope-based, psychoeducational, or psychotherapeutic programs) during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bartın University
Bartın, Bartın, 74100, Turkey (Türkiye)
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Experimental: Intervention Group Participants in the intervention group received the Hope-Focused Motivational Interviewing program, which consisted of four sessions delivered twice weekly. Intervention: Behavioral - Motivational Interviewing Control: Control Group Participants in the control group received routine care and no structured psychosocial intervention during the study period. Data were collected at the same time points as in the intervention group.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
May 2, 2026
First Posted
May 14, 2026
Study Start (Estimated)
June 15, 2026
Primary Completion (Estimated)
October 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
May 14, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share